A sister protein, known as amylin, which comes from the pancreas of diabetic patients, has the same effect on memory cells. Jhamandas and his group demonstrated last year that a diabetes medication that never managed to get to market, referred to as AC253, could block the toxic ramifications of amyloid protein that lead to brain cell loss of life. In the lab, Jhamandas and his teammates, including Ryoichi Kimura, a going to scientist from Japan, examined the memory space of normal human brain cells and the ones with Alzheimer's-both from animal models.Is helping fund.S. Will be required to cut back its support of HIV/AIDS programs on the ground. A full video from the program is available here. CBSNews. This content is normally republished with kind permission from our close friends at The Kaiser Family members Foundation. You will see the complete Kaiser Daily Health Plan Record, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, discussions and debates. The Kaiser Daily Health Policy Report is released for Kaisernetwork.org, a free of charge provider of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Affymetrix second quarter total revenue increases to $66.4 million Affymetrix, Inc., today reported its operating results for the second quarter of 2012.